Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Daïen CI[au]:

Search results

Items: 27

1.

Relevance and feasibility of a systematic screening of multimorbidities in patients with chronic inflammatory rheumatic diseases.

Daïen CI, Tubery A, Beurai-Weber M, du Cailar G, Picot MC, Jaussent A, Roubille F, Cohen JD, Morel J, Bousquet J, Fesler P, Combe B.

Joint Bone Spine. 2019 Jan;86(1):49-54. doi: 10.1016/j.jbspin.2018.03.016. Epub 2018 Apr 11.

PMID:
29654949
2.

PhosphoLipid transfer protein (PLTP) exerts a direct pro-inflammatory effect on rheumatoid arthritis (RA) fibroblasts-like-synoviocytes (FLS) independently of its lipid transfer activity.

Audo R, Deckert V, Daien CI, Che H, Elhmioui J, Lemaire S, Pais de Barros JP, Desrumaux C, Combe B, Hahne M, Lagrost L, Morel J.

PLoS One. 2018 Mar 22;13(3):e0193815. doi: 10.1371/journal.pone.0193815. eCollection 2018.

3.

Diabetes at the time of rheumatoid arthritis diagnosis is an independent predictor of pejorative outcomes: Data from the early arthritis ESPOIR cohort.

Daïen CI, Sellam J, Rincheval N, Fautrel B, Saraux A, Morel J, Berenbaum F, Daurès JP, Combe B.

Joint Bone Spine. 2018 Dec;85(6):773-775. doi: 10.1016/j.jbspin.2018.02.004. Epub 2018 Feb 23. No abstract available.

PMID:
29481873
4.

Sodium excretion is higher in patients with rheumatoid arthritis than in matched controls.

Marouen S, du Cailar G, Audo R, Lukas C, Vial G, Tournadre A, Barrat E, Ribstein J, Combe B, Morel J, Daien CI.

PLoS One. 2017 Oct 13;12(10):e0186157. doi: 10.1371/journal.pone.0186157. eCollection 2017.

5.

Lymphocytes as Biomarkers of Therapeutic Response in Rheumatic Autoimmune Diseases, Is It a Realistic Goal?

Schreiber K, Nocturne G, Cornec D, Daïen CI.

Clin Rev Allergy Immunol. 2017 Oct;53(2):277-290. doi: 10.1007/s12016-017-8614-7. Review.

PMID:
28560621
6.

Detrimental Impact of Microbiota-Accessible Carbohydrate-Deprived Diet on Gut and Immune Homeostasis: An Overview.

Daïen CI, Pinget GV, Tan JK, Macia L.

Front Immunol. 2017 May 12;8:548. doi: 10.3389/fimmu.2017.00548. eCollection 2017. Review.

7.

Application of the 2015/2016 EULAR recommendations for cardiovascular risk in daily practice: data from an observational study.

Daïen CI, Tubery A, Cailar GD, Mura T, Roubille F, Morel J, Bousquet J, Fesler P, Combe B.

Ann Rheum Dis. 2018 Apr;77(4):625-626. doi: 10.1136/annrheumdis-2017-211074. Epub 2017 May 6. No abstract available.

PMID:
28478400
8.

Could Lymphocyte Profiling be Useful to Diagnose Systemic Autoimmune Diseases?

Carvajal Alegria G, Gazeau P, Hillion S, Daïen CI, Cornec DYK.

Clin Rev Allergy Immunol. 2017 Oct;53(2):219-236. doi: 10.1007/s12016-017-8608-5. Review.

PMID:
28474288
9.
10.
11.

Phosphatidylserine Outer Layer Translocation Is Implicated in IL-10 Secretion by Human Regulatory B Cells.

Audo R, Hua C, Hahne M, Combe B, Morel J, Daien CI.

PLoS One. 2017 Jan 10;12(1):e0169755. doi: 10.1371/journal.pone.0169755. eCollection 2017.

12.

2016 update of the EULAR recommendations for the management of early arthritis.

Combe B, Landewe R, Daien CI, Hua C, Aletaha D, Álvaro-Gracia JM, Bakkers M, Brodin N, Burmester GR, Codreanu C, Conway R, Dougados M, Emery P, Ferraccioli G, Fonseca J, Raza K, Silva-Fernández L, Smolen JS, Skingle D, Szekanecz Z, Kvien TK, van der Helm-van Mil A, van Vollenhoven R.

Ann Rheum Dis. 2017 Jun;76(6):948-959. doi: 10.1136/annrheumdis-2016-210602. Epub 2016 Dec 15.

13.

TNF inhibitors increase fat mass in inflammatory rheumatic disease: a systematic review with meta-analysis.

Marouen S, Barnetche T, Combe B, Morel J, Daïen CI.

Clin Exp Rheumatol. 2017 Mar-Apr;35(2):337-343. Epub 2016 Dec 13. Review.

PMID:
27974099
14.

Clinical association of mixed connective tissue disease and granulomatosis with polyangiitis: a case report and systematic screening of anti-U1RNP and anti-PR3 auto-antibody double positivity in ten European hospitals.

Tubery A, Fortenfant F, Combe B, Abreu I, Bossuyt X, Chretien P, Desplat-Jégo S, Fabien N, Hue S, Johanet C, Lakomy D, Vincent T, Daïen CI.

Immunol Res. 2016 Dec;64(5-6):1243-1246.

PMID:
27618831
15.

Obesity and inflammatory arthritis: impact on occurrence, disease characteristics and therapeutic response.

Daïen CI, Sellam J.

RMD Open. 2015 Jun 29;1(1):e000012. doi: 10.1136/rmdopen-2014-000012. eCollection 2015. Review.

16.

High levels of natural killer cells are associated with response to tocilizumab in patients with severe rheumatoid arthritis.

Daïen CI, Gailhac S, Audo R, Mura T, Hahne M, Combe B, Morel J.

Rheumatology (Oxford). 2015 Apr;54(4):601-8. doi: 10.1093/rheumatology/keu363. Epub 2014 Sep 16.

PMID:
25231180
17.
18.

Regulatory B10 cells are decreased in patients with rheumatoid arthritis and are inversely correlated with disease activity.

Daien CI, Gailhac S, Mura T, Audo R, Combe B, Hahne M, Morel J.

Arthritis Rheumatol. 2014 Aug;66(8):2037-46. doi: 10.1002/art.38666.

19.

Predictive factors of response to biological disease modifying antirheumatic drugs: towards personalized medicine.

Daïen CI, Morel J.

Mediators Inflamm. 2014;2014:386148. doi: 10.1155/2014/386148. Epub 2014 Jan 12. Review.

20.

Etanercept normalises left ventricular mass in patients with rheumatoid arthritis.

Daïen CI, Fesler P, du Cailar G, Daïen V, Mura T, Dupuy AM, Cristol JP, Ribstein J, Combe B, Morel J.

Ann Rheum Dis. 2013 Jun;72(6):881-7. doi: 10.1136/annrheumdis-2012-201489. Epub 2012 Aug 7.

PMID:
22872022
21.

Etanercept concentration in patients with rheumatoid arthritis and its potential influence on treatment decisions: a pilot study.

Daïen CI, Daïen V, Parussini E, Dupuy AM, Combe B, Morel J.

J Rheumatol. 2012 Aug;39(8):1533-8. doi: 10.3899/jrheum.111522. Epub 2012 Jul 1.

PMID:
22753654
22.

Effect of TNF inhibitors on lipid profile in rheumatoid arthritis: a systematic review with meta-analysis.

Daïen CI, Duny Y, Barnetche T, Daurès JP, Combe B, Morel J.

Ann Rheum Dis. 2012 Jun;71(6):862-8. doi: 10.1136/annrheumdis-2011-201148. Epub 2012 Jan 20. Review.

PMID:
22267329
23.

TGF beta1 polymorphisms are candidate predictors of the clinical response to rituximab in rheumatoid arthritis.

Daïen CI, Fabre S, Rittore C, Soler S, Daïen V, Tejedor G, Cadart D, Molinari N, Daurès JP, Jorgensen C, Touitou I.

Joint Bone Spine. 2012 Oct;79(5):471-5. doi: 10.1016/j.jbspin.2011.10.007. Epub 2011 Nov 29.

PMID:
22129793
24.

[Rheumatoid arthritis: a cardiovascular disease?].

Daïen CI, Fesler P.

Ann Cardiol Angeiol (Paris). 2012 Apr;61(2):111-7. doi: 10.1016/j.ancard.2011.07.008. Epub 2011 Aug 17. Review. French.

PMID:
21885031
25.

Whipple's endocarditis as a complication of tumour necrosis factor-alpha antagonist treatment in a man with ankylosing spondylitis.

Daïen CI, Cohen JD, Makinson A, Battistella P, Jumas Bilak E, Jorgensen C, Reynes J, Raoult D.

Rheumatology (Oxford). 2010 Aug;49(8):1600-2. doi: 10.1093/rheumatology/keq089. Epub 2010 Apr 5. No abstract available.

PMID:
20371501
26.

Zoster cruralgia in a pregnant woman.

Daïen CI, Cohen JD, Jorgensen C.

Joint Bone Spine. 2009 Dec;76(6):724-5. doi: 10.1016/j.jbspin.2009.04.008. No abstract available.

PMID:
19945328
27.

Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases.

Daïen CI, Monnier A, Claudepierre P, Constantin A, Eschard JP, Houvenagel E, Samimi M, Pavy S, Pertuiset E, Toussirot E, Combe B, Morel J; Club Rhumatismes et Inflammation (CRI).

Rheumatology (Oxford). 2009 Aug;48(8):883-6. doi: 10.1093/rheumatology/kep046. Epub 2009 May 7. Review.

PMID:
19423648

Supplemental Content

Loading ...
Support Center